Florida’s Equine Landscape
Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake – Diagnosing Health Care
AI Law in the Commonwealth of Virginia - Recent Developments
Proof in Trial: Moore v. Harper
Video: Things to Remember in Q1 when Preparing 2024 Federal Lobbying Disclosure Act (LDA) Reports
Podcast: Discussing Florida’s 2024 Legislative Session
33rd Annual Legislative Seminar - Senator Shelley Moore Capito, R-W.Va.
33rd Annual Legislative Seminar - Congressman Raja Krishnamoorthi, D-Ill
Orrick Public Policy Podcast #23 – A Conversation with Virginia Delegate Schuyler VanValkenburg
Overview of 87th Texas Legislature
Labor & Employment Law: Vermont and Federal Legislative Update
Lowndes Client Corner Podcast Episode 5 - Winter Park Distilling Company Brews One-Of-A-Kind Facility in Winter Park
On February 16, the U. S. District Court for the District of Oregon struck down the state’s drug price transparency law—The Prescription Drug Price Transparency Act (the “Act”)—ruling that the Act’s annual price increase...more
State legislatures continue to push forward on drug pricing with legislation designed to reduce the cost of prescription drugs. Recent steps across a number of states include laying the groundwork for effective...more
With proposed federal legislation on pause, state legislatures continue to target the pricing of pharmaceuticals, passing a number of new laws in 2020. As complexity at the state level continues to increase, pharmaceutical...more
In 2019, U.S. Department of Justice (DOJ) enforcement activity targeting drug and device manufacturers jumped sharply over the prior year, reflecting an increased focus on fraud and abuse in the life sciences sector. More...more